Post-bronchodilator values for FEV@ and FVC were analyzed for subjects completing at least the @ year visit ( Placebo - N = @ ; Tiotropium - N = @ ) , stratified by GOLD stage , age , gender and smoking status and expressed as absolute , relative ( % ) and % predicted changes from pre-bronchodilator values .